Bone Marrow TransplantationCord Blood Stem Cell TransplantationFetal BloodTransplantation, HomologousGraft vs Host DiseaseBone MarrowTissue DonorsHematopoietic Stem Cell TransplantationTransplantation ChimeraHistocompatibility TestingTransplantation ConditioningBone Marrow CellsHematologic NeoplasmsGraft SurvivalTreatment OutcomeKidney TransplantationTransplantation, AutologousWhole-Body IrradiationGraft RejectionBone and BonesLiver TransplantationAnemia, AplasticHistocompatibilityLeukemiaImmunosuppressive AgentsHematopoietic Stem CellsTime FactorsLung TransplantationBusulfanBone Marrow PurgingRetrospective StudiesRecurrenceImmunosuppressionTransplantation, IsogeneicHLA AntigensCyclophosphamideTransplantationBone Marrow DiseasesHematopoiesisSurvival AnalysisCombined Modality TherapyHeart TransplantationTissue and Organ ProcurementMice, Inbred C57BLAcute DiseaseRadiation ChimeraLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiving DonorsFollow-Up StudiesSpinal CordSurvival RateTransplantation ImmunologyBone Marrow ExaminationPrecursor Cell Lymphoblastic Leukemia-LymphomaIslets of Langerhans TransplantationDelayed Graft FunctionRemission InductionPrimary Graft DysfunctionStem Cell TransplantationHepatic Veno-Occlusive DiseaseBone RemodelingLeukemia, MyeloidGraft vs Host ReactionBone Marrow NeoplasmsCyclosporineLymphocyte DepletionColony-Forming Units AssayPrognosisT-LymphocytesLymphoma, Non-HodgkinLeukocyte TransfusionAntigens, CD34Severe Combined ImmunodeficiencyMyelodysplastic SyndromesChimeraDonor SelectionWaiting ListsHematologic DiseasesCytomegalovirus InfectionsCell DifferentiationRisk FactorsActuarial AnalysisTransplantsLymphocyte TransfusionBone DensityAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilySpinal Cord InjuriesFlow CytometryCells, CulturedPostoperative ComplicationsGraft vs Leukemia EffectLeukocyte CountCarmustineProspective StudiesKidney Failure, ChronicGraft vs Tumor EffectOrgan TransplantationPancytopenia